Roles of HNF1α and HNF4α in pancreatic β-cells: Lessons from a monogenic form of diabetes (MODY)

Vitamins and Hormones

Volumn 95, Issue , 2014, Pages 407-423

  Yamagata, Kazuya ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Anks4b; Collectrin; Diabetes; Gene; Hepatocyte growth factor activator; Hepatocyte nuclear factor 1 ; HNF1 ; HNF4 ; Insulin secretion; Maturity onset diabetes of the young; Transcription factor

Indexed keywords

HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 4; HNF1A PROTEIN, HUMAN; HNF4A PROTEIN, HUMAN; INSULIN;

ANIMAL; BIOLOGICAL MODEL; CELL PROLIFERATION; CYTOLOGY; ENDOPLASMIC RETICULUM STRESS; GENETICS; HUMAN; METABOLISM; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; PANCREAS ISLET BETA CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CELL PROLIFERATION; DIABETES MELLITUS, TYPE 2; ENDOPLASMIC RETICULUM STRESS; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; INSULIN; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; MUTATION; PANCREAS;

EID: 84894042178     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800174-5.00016-8     Document Type: Chapter

References (98)

1. Akpinar P., Kuwajima S., Krützfeldt J., Stoffel M. Tmem27: A cleaved and shed plasma membrane protein that stimulates pancreatic beta cell proliferation. Cell Metabolism 2005, 2(6):385-397.
2. Altirriba J., Gasa R., Casas S., Ramírez-Bajo M.J., Ros S., Gutierrez-Dalmau A., et al. The role of transmembrane protein 27 (TMEM27) in islet physiology and its potential use as a β cell mass biomarker. Diabetologia 2010, 53(7):1406-1414.
3. Awa W.L., Thon A., Raile K., Grulich-Henn J., Meissner T., Schober E., et al. Genetic and clinical characteristics of patients with HNF1A gene variations from the German-Austrian DPV database. European Journal of Endocrinology 2011, 164(4):513-520.
4. Bazalová Z., Rypácková B., Broz J., Brunerová L., Polák J., Rusavý Z., et al. Three novel mutations in MODY and its phenotype in three different Czech families. Diabetes Research and Clinical Practice 2010, 88(2):132-138.
5. Bell G.I., Xiang K.S., Newman M.V., Wu S.H., Wright L.G., Fajans S.S., et al. Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proceedings of the National Academy of Sciences of the United States of America 1991, 88(4):1484-1488.
6. Bellanné-Chantelot C., Carette C., Riveline J.P., Valéro R., Gautier J.F., Larger E., et al. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes 2008, 57(2):503-508.
7. Bellanné-Chantelot C., Chauveau D., Gautier J.F., Dubois-Laforgue D., Clauin S., Beaufils S., et al. Clinical spectrum associated with hepatocyte nuclear factor-1β mutations. Annals of Internal Medicine 2004, 140(7):510-517.
8. Boj S.F., Parrizas M., Maestro M.A., Ferrer J. A transcription factor regulatory circuit in differentiated pancreatic cells. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(25):14481-14486.
9. Boj S.F., Petrov D., Ferrer J. Epistasis of transcriptomes reveals synergism between transcriptional activators Hnf1alpha and Hnf4alpha. PLoS Genetics 2010, 6(5):e1000970.
10. Bonnefond A., Philippe J., Durand E., Dechaume A., Huyvaert M., Montagne L., et al. Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PLoS One 2012, 7(6):e37423.
11. Borowiec M., Liew C.W., Thompson R., Boonyasrisawat W., Hu J., Mlynarski W.M., et al. Mutations at the BLK locus linked to maturity onset diabetes of the young and β-cell dysfunction. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:14460-14465.
12. Bowman P., Flanagan S.E., Edghill E.L., Damhuis A., Shepherd M.H., Paisey R., et al. Heterozygous ABCC8 mutations are a cause of MODY. Diabetologia 2012, 55(1):123-127.
13. Buchbinder S., Zorn M., Bierhaus A., Nawroth P.P., Müller M., Schilling T. Maturity-onset diabetes of the young (MODY) caused by a novel nonsense mutation E41X in the HNF-1α gene. Experimental and Clinical Endocrinology & Diabetes 2011, 119(3):182-185.
14. Byrne M.M., Sturis J., Fajans S.S., Ortiz F.J., Stoltz A., Stoffel M., et al. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes 1995, 44(6):699-704.
15. Byrne M.M., Sturis J., Menzel S., Yamagata K., Fajans S.S., Dronsfield M.J., et al. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 1996, 45(11):1503-1510.
16. Cappelli A., Tumini S., Consoli A., Carinci S., Piersanti C., Ruggiero G., et al. Novel mutations in GCK and HNF1A genes in Italian families with MODY phenotype. Diabetes Research and Clinical Practice 2009, 83(3):e72-e74.
17. Carette C., Dubois-Laforgue D., Saint-Martin C., Clauin S., Beaufils S., Larger E., et al. Familial young-onset forms of diabetes related to HNF4A and rare HNF1A molecular aetiologies. Diabetic Medicine 2010, 27(12):1454-1458.
18. Chen W.S., Manova K., Weinstein D.C., Duncan S.A., Plump A.S., Prezioso V.R., et al. Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. Genes and Development 1994, 8(20):2466-2477.
19. Conn J.J., Simm P.J., Oats J.J., Nankervis A.J., Jacobs S.E., Ellard S., et al. Neonatal hyperinsulinaemic hypoglycaemia and monogenic diabetes due to a heterozygous mutation of the HNF4A gene. Australian and New Zealand Journal of Obstetrics and Gynaecology 2009, 49(3):328-330.
20. Demirci C., Ernst S., Alvarez-Perez J.C., Rosa T., Valle S., Shridhar V., et al. Loss of HGF/c-Met signaling in pancreatic β-cells leads to incomplete maternal β-cell adaptation and gestational diabetes mellitus. Diabetes 2012, 61:1143-1152.
21. Dukes I.D., Sreenan S., Roe M.W., Levisetti M., Zhou Y.P., Ostrega D., et al. Defective pancreatic β-cell glycolytic signaling in hepatocyte nuclear factor-1α-deficient mice. Journal of Biological Chemistry 1998, 273(38):24457-24464.
22. Edghill E.L., Flanagan S.E., Patch A.M., Boustred C., Parrish A., Shields B., et al. Insulin mutation screening in 1,044 patients with diabetes: Mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008, 57:1034-1042.
23. Eide S.A., Raeder H., Johansson S., Midthjell K., Søvik O., Njølstad P.R., et al. Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabetic Medicine 2008, 25(7):775-781.
24. Ellard S., Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Human Mutation 2006, 27(9):854-869.
25. Ellard S., Thomas K., Edghill E.L., Owens M., Ambye L., Cropper J., et al. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia 2007, 50(11):2313-2317.
26. Fajans S.S., Bell G.I. MODY: History, genetics, pathophysiology, and clinical decision making. Diabetes Care 2011, 34(8):1878-1884.
27. Flanagan S.E., Kapoor R.R., Mali G., Cody D., Murphy N., Schwahn B., et al. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. European Journal of Endocrinology 2010, 162(5):987-992.
28. Forlani G., Zucchini S., Di Rocco A., Di Luzio R., Scipione M., Marasco E., et al. Double heterozygous mutations involving both HNF1A/MODY3 and HNF4A/MODY1 genes. Diabetes Care 2010, 33(11):2336-2338.
29. Frain M., Swart G., Monaci P., Nicosia A., Stämpfli S., Frank R., et al. The liver-specific transcription factor LF-B1 contains a highly diverged homeobox DNA binding domain. Cell 1989, 59:145-157.
30. Frayling T.M., Evans J.C., Bulman M.P., Pearson E., Allen L., Owen K., et al. β-Cell genes and diabetes: Molecular and clinical characterization of mutations in transcription factors. Diabetes 2001, 50(Suppl. 1):S94-S100.
31. Fukui K., Yang Q., Cao Y., Takahashi N., Hatakeyama H., Wang H., et al. The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metabolism 2005, 2(6):373-384.
32. Garcia-Ocaña A., Takane K.K., Syed M.A., Philbrick W.M., Vasavada R.C., Stewart A.F. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. Journal of Biological Chemistry 2000, 275:1226-1232.
33. Gunton J.E., Kulkarni R.N., Yim S., Okada T., Hawthorne W.J., Tseng Y.H., et al. Loss of ARNT/HIF1β mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 2005, 122(3):337-349.
34. Gupta R.K., Gao N., Gorski R.K., White P., Hardy O.T., Rafiq K., et al. Expansion of adult β-cell mass in response to increased metabolic demand is dependent on HNF-4α. Genes and Development 2007, 21(7):756-769.
35. Gupta R.K., Vatamaniuk M.Z., Lee C.S., Flaschen R.C., Fulmer J.T., Matschinsky F.M., et al. The MODY1 gene HNF-4α regulates selected genes involved in insulin secretion. Journal of Clinical Investigation 2005, 115(4):1006-1015.
36. Hadzopoulou-Cladaras M., Kistanova E., Evagelopoulou C., Zeng S., Cladaras C., Ladias J.A. Functional domains of the nuclear receptor hepatocyte nuclear factor 4. Journal of Biological Chemistry 1997, 272(1):539-550.
37. Hagenfeldt-Johansson K.A., Herrera P.L., Wang H., Gjinovci A., Ishihara H., Wollheim C.B. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1 alpha induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology 2001, 142(12):5311-5320.
38. Hattersley A.T., Pearson E.R. Minireview: Pharmacogenetics and beyond: The interaction of therapeutic response, β-cell physiology, and genetics in diabetes. Endocrinology 2006, 147(6):2657-2663.
39. Horikawa Y., Iwasaki N., Hara M., Furuta H., Hinokio Y., Cockburn B.N., et al. Mutation in hepatocyte nuclear factor-1 β gene (TCF2) associated with MODY. Nature Genetics 1997, 17(4):384-385.
40. Ihara A., Yamagata K., Nammo T., Miura A., Yuan M., Tanaka T., et al. Functional characterization of the HNF4α isoform (HNF4α8) expressed in pancreatic β-cells. Biochemical and Biophysical Research Communications 2005, 329(3):984-990.
41. Isomaa B., Henricsson M., Lehto M., Forsblom C., Karanko S., Sarelin L., et al. Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 1998, 41(4):467-473.
42. Iwasaki N., Ogata M., Tomonaga O., Kuroki H., Kasahara T., Yano N., et al. Liver and kidney function in Japanese patients with maturity-onset diabetes of the young. Diabetes Care 1998, 21(12):2144-2148.
43. Jesić M.D., Sajić S., Jesić M.M., Maringa M., Micić D., Necić S. A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea. Diabetes Research and Clinical Practice 2008, 81(1):e1-e3.
44. Johnston A.M., Naselli G., Niwa H., Brodnicki T., Harrison L.C., Góñez L.J. Harp (harmonin-interacting, ankyrin repeat-containing protein), a novel protein that interacts with harmonin in epithelial tissues. Genes to Cells 2004, 9(10):967-982.
45. Kapoor R.R., Locke J., Colclough K., Wales J., Conn J.J., Hattersley A.T., et al. Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4A mutations. Diabetes 2008, 57(6):1659-1663.
46. Karges B., Bergmann C., Scholl K., Heinze E., Rasche F.M., Zerres K., et al. Digenic inheritance of hepatocyte nuclear factor-1α and -1β with maturity-onset diabetes of the young, polycystic thyroid, and urogenital malformations. Diabetes Care 2007, 30(6):1613-1614.
47. Kooptiwut S., Sujjitjoon J., Plengvidhya N., Boonyasrisawat W., Chongjaroen N., Jungtrakoon P., et al. Functional defect of truncated hepatocyte nuclear factor-1α (G554fsX556) associated with maturity-onset diabetes of the young. Biochemical and Biophysical Research Communications 2009, 383(1):68-72.
48. Kuo C.J., Conley P.B., Chen L., Sladek F.M., Darnell J.E., Crabtree G.R. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 1992, 355(6359):457-461.
49. Kyithar M.P., Bacon S., Pannu K.K., Rizvi S.R., Colclough K., Ellard S., et al. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: Phenotypic characteristics and therapeutic implications. Diabetes & Metabolism 2011, 37(6):512-519.
50. Lopez A.P., Foscaldi S.A., Perez M.S., Rodriguez M., Traversa M., Puchulu F.M., et al. HNF1 α gene coding regions mutations screening, in a Caucasian population clinically characterized as MODY from Argentina. Diabetes Research and Clinical Practice 2011, 91(2):208-212.
51. Lorini R., Klersy C., d'Annunzio G., Massa O., Minuto N., Iafusco D., et al. Maturity-onset diabetes of the young in children with incidental hyperglycemia: A multicenter Italian study of 172 families. Diabetes Care 2009, 32(10):1864-1866.
52. Love-Gregory L.D., Wasson J., Ma J., Jin C.H., Glaser B., Suarez B.K., et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 2004, 53(4):1134-1140.
53. Maestro M.A., Cardalda C., Boj S.F., Luco R.F., Servitja J.M., Ferrer J. Distinct roles of HNF1β, HNF1α, and HNF4α in regulating pancreas development, β-cell function and growth. Endocrine Development 2007, 12:33-45.
54. Malecki M.T., Jhala U.S., Antonellis A., Fields L., Doria A., Orban T., et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nature Genetics 1999, 23:323-328.
55. Maraschin Jde F., Kannengiesser C., Murussi N., Campagnolo N., Canani L.H., Gross J.L., et al. HNF1α mutations are present in half of clinically defined MODY patients in South-Brazilian individuals. Arquivos Brasileiros de Endocrinologia e Metabologia 2008, 52(8):1326-1331.
56. Mellado-Gil J., Rosa T.C., Demirci C., Gonzalez-Pertusa J.A., Velazquez-Garcia S., Ernst S., et al. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic β-cell death and accelerates the onset of diabetes. Diabetes 2011, 60:525-536.
57. Mendel D.B., Crabtree G.R. HNF-1, a member of a novel class of dimerizing homeodomain proteins. Journal of Biological Chemistry 1991, 266:677-680.
58. Miura A., Yamagata K., Kakei M., Hatakeyama H., Takahashi N., Fukui K., et al. Hepatocyte nuclear factor-4α is essential for glucose-stimulated insulin secretion by pancreatic β-cells. Journal of Biological Chemistry 2006, 281(8):5246-5257.
59. Miyazawa K. Hepatocyte growth factor activator (HGFA): A serine protease that links tissue injury to activation of hepatocyte growth factor. The FEBS Journal 2010, 277:2208-2214.
60. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989, 342:440-443.
61. Nammo T., Yamagata K., Hamaoka R., Zhu Q., Akiyama T.E., Gonzalez F.J., et al. Expression profile of MODY3/HNF-1α protein in the developing mouse pancreas. Diabetologia 2002, 45:1142-1153.
62. Nammo T., Yamagata K., Tanaka T., Kodama T., Sladek F.M., Fukui K., et al. Expression of HNF-4α (MODY1), HNF-1β (MODY5), and HNF-1α (MODY3) proteins in the developing mouse pancreas. Gene Expression Patterns 2008, 8(2):96-106.
63. Neve B., Fernandez-Zapico M.E., Ashkenazi-Katalan V., Dina C., Hamid Y.H., Joly E., et al. Role of transcription factor KLF11 and its diabetes-associated gene variants in pancreatic β cell function. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:4807-4812.
64. Ohki T., Sato Y., Yoshizawa T., Yamamura K., Yamada K., Yamagata K. Identification of hepatocyte growth factor activator (Hgfac) gene as a target of HNF1α in mouse β-cells. Biochemical and Biophysical Research Communications 2012, 425(3):619-624.
65. Párrizas M., Maestro M.A., Boj S.F., Paniagua A., Casamitjana R., Gomis R., et al. Hepatic nuclear factor 1-α directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Molecular and Cellular Biology 2001, 21(9):3234-3243.
66. Pearson E.R., Boj S.F., Steele A.M., Barrett T., Stals K., Shield J.P., et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Medicine 2007, 4(4):e118.
67. Pearson E.R., Starkey B.J., Powell R.J., Gribble F.M., Clark P.M., Hattersley A.T. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003, 362(9392):1275-1281.
68. Plengvidhya N., Boonyasrisawat W., Chongjaroen N., Jungtrakoon P., Sriussadaporn S., Vannaseang S., et al. Mutations of maturity-onset diabetes of the young (MODY) genes in Thais with early-onset type 2 diabetes mellitus. Clinical Endocrinology 2009, 70(6):847-853.
69. Plengvidhya N., Kooptiwut S., Songtawee N., Doi A., Furuta H., Nishi M., et al. PAX4 mutations in Thais with maturity onset diabetes of the young. Journal of Clinical Endocrinology & Metabolism 2007, 92:2821-2826.
70. Pontoglio M., Barra J., Hadchouel M., Doyen A., Kress C., Bach J.P., et al. Hepatocyte nuclear factor 1 inactivation results in hepatic dysfunction, phenylketonuria, and renal Fanconi syndrome. Cell 1996, 84(4):575-585.
71. Pontoglio M., Sreenan S., Roe M., Pugh W., Ostrega D., Doyen A., et al. Defective insulin secretion in hepatocyte nuclear factor 1α-deficient mice. Journal of Clinical Investigation 1998, 101(10):2215-2222.
72. Radha V., Ek J., Anuradha S., Hansen T., Pedersen O., Mohan V. Identification of novel variants in the hepatocyte nuclear factor-1α gene in South Indian patients with maturity onset diabetes of young. Journal of Clinical Endocrinology and Metabolism 2009, 94(6):1959-1965.
73. Raeder H., Johansson S., Holm P.I., Haldorsen I.S., Mas E., Sbarra V., et al. Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction. Nature Genetics 2006, 38:54-62.
74. Sato Y., Hatta M., Karim M.F., Sawa T., Wei F.Y., Sato S., et al. Anks4b, a novel target of HNF4α protein, interacts with GRP78 protein and regulates endoplasmic reticulum stress-induced apoptosis in pancreatic β-cells. Journal of Biological Chemistry 2012, 287(27):23236-23245.
75. Servitja J.M., Pignatelli M., Maestro M.A., Cardalda C., Boj S.F., Lozano J., et al. Hnf1α (MODY3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver. Molecular and Cellular Biology 2009, 29(11):2945-2959.
76. Shih D.Q., Screenan S., Munoz K.N., Philipson L., Pontoglio M., Yaniv M., et al. Loss of HNF-1α function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 2001, 50(11):2472-2480.
77. Silander K., Mohlke K.L., Scott L.J., Peck E.C., Hollstein P., Skol A.D., et al. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes 2004, 53(4):1141-1149.
78. Sladek F.M. Orphan receptor HNF-4 and liver-specific gene expression. Receptor 1993, 3(3):223-232.
79. Sladek F.M., Zhong W.M., Lai E., Darnell J.E. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes and Development 1990, 4(12B):2353-2365.
80. Stanescu D.E., Hughes N., Kaplan B., Stanley C.A., De León D.D. Novel presentations of congenital hyperinsulinism due to mutations in the MODY genes: HNF1A and HNF4A. Journal of Clinical Endocrinology and Metabolism 2012, 97(10):E2026-E2030.
81. Stoffel M., Duncan S.A. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(24):13209-13214.
82. Stoffers D.A., Ferrer J., Clarke W.L., Habener J.F. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nature Genetics 1997, 17(2):138-139.
83. Tattersall R.B. Mild familial diabetes with dominant inheritance. Quarterly Journal of Medicine 1974, 43(170):339-357.
84. Thomas H., Jaschkowitz K., Bulman M., Frayling T.M., Mitchell S.M., Roosen S., et al. A distant upstream promoter of the HNF-4α gene connects the transcription factors involved in maturity-onset diabetes of the young. Human Molecular Genetics 2001, 10(19):2089-2097.
85. Toaima D., Näke A., Wendenburg J., Praedicow K., Rohayem J., Engel K., et al. Identification of novel GCK and HNF1A/TCF1 mutations and polymorphisms in German families with maturity-onset diabetes of the young (MODY). Human Mutation 2005, 25(5):503-504.
86. Triggs-Raine B.L., Kirkpatrick R.D., Kelly S.L., Norquay L.D., Cattini P.A., Yamagata K., et al. HNF-1α G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(7):4614-4619.
87. Vionnet N., Stoffel M., Takeda J., Yasuda K., Bell G.I., Zouali H., et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 1992, 356(6371):721-722.
88. Voight B.F., Scott L.J., Steinthorsdottir V., Morris A.P., Dina C., Welch R.P., et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nature Genetics 2010, 42(7):579-589.
89. Wang H., Maechler P., Hagenfeldt K.A., Wollheim C.B. Dominant-negative suppression of HNF-1α function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic β-cell line. The EMBO Journal 1998, 17(22):6701-6713.
90. Yamagata K., Furuta H., Oda N., Kaisaki P.J., Menzel S., Cox N.J., et al. Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 1996, 384(6608):458-460.
91. Yamagata K., Nammo T., Moriwaki M., Ihara A., Iizuka K., Yang Q., et al. Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 α in pancreatic β-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced β-cell proliferation, and diabetes. Diabetes 2002, 51(1):114-123.
92. Yamagata K., Nammo T., Sato Y., Saisho K., Shoda H., Fukui K. The HNF-1α-SNARE connection. Diabetes, Obesity & Metabolism 2007, 9(Suppl. 2):40-45.
93. Yamagata K., Oda N., Kaisaki P.J., Menzel S., Furuta H., Vaxillaire M., et al. Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3). Nature 1996, 384(6608):455-458.
94. Yamagata K., Yang Q., Yamamoto K., Iwahashi H., Miyagawa J., Okita K., et al. Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-1alpha is dominant negative. Diabetes 1998, 47(8):1231-1235.
95. Yang Q., Yamagata K., Fukui K., Cao Y., Nammo T., Iwahashi H., et al. Hepatocyte nuclear factor-1α modulates pancreatic β-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells. Diabetes 2002, 51(6):1785-1792.
96. Yorifuji T., Fujimaru R., Hosokawa Y., Tamagawa N., Shiozaki M., Aizu K., et al. Comprehensive molecular analysis of Japanese patients with pediatric-onset MODY-type diabetes mellitus. Pediatric Diabetes 2012, 13(1):26-32.
97. Yoshiuchi I., Yamagata K., Yang Q., Iwahashi H., Okita K., Yamamoto K., et al. Three new mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with diabetes mellitus: Clinical features and functional characterization. Diabetologia 1999, 42(5):621-626.
98. Zhang H., Wada J., Hida K., Tsuchiyama Y., Hiragushi K., Shikata K., et al. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. Journal of Biological Chemistry 2001, 276(20):17132-17139.